Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (Chemo)radiation: The impact of treatment modality and radiation technique

The main goal of the current study was to comprehensively address the impact of chemoradiation and radiation techniques on toxicity, quality of life (QoL), and functional outcome.

[1]  F. Feng,et al.  Clinical Investigation : Head and Neck Cancer Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer : Beyond Sparing the Parotid Glands , 2012 .

[2]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[3]  P. Dirix,et al.  Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma. , 2010, International journal of radiation oncology, biology, physics.

[4]  N. Khaouam,et al.  Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding? , 2010, International journal of radiation oncology, biology, physics.

[5]  D. Rietveld,et al.  A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  K. Ang,et al.  Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary. , 2009, International journal of radiation oncology, biology, physics.

[7]  P. Levendag,et al.  Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  N. Mohamed,et al.  Turning the tide: benefit finding after cancer surgery. , 2004, Social science & medicine.

[9]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[10]  P. Fayers,et al.  A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. , 2000, European journal of cancer.